跳至主要内容
临床试验/EUCTR2014-005145-51-DE
EUCTR2014-005145-51-DE进行中(未招募)1 期

A randomised controlled multicenter trial comparing ultrasound-accelerated catheter-directed thrombolysis, combined with standard anticoagulant therapy, with standard anticoagulant therapy alone, for acute primary iliofemoral deep vein thrombosis - CAVA

Maastricht University Medical Centre0 个研究点目标入组 180 人开始时间: 2015年8月18日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients aged between 18-65 years
  • Written informed consent prior to study participation
  • First thrombus in the affected limb
  • Objectively documented IFDVT on compression ultrasound.
  • Acute stage IFDVT, complaints less than 14 days
  • Life expectancy longer than 6 months
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 170
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 10

排除标准

  • Previous thrombosis of the affected limb (secondary thrombosis)
  • Surgery within 2 weeks
  • Varicosities/venous insufficiency CEAP classification C3 or higher.
  • History of GI bleeding within 3 months
  • History of CVA/central nervous system disease within 12 months
  • Severe hypertension (>180/100 mmHg)
  • ALT > 3 times normal range
  • eGFR < 30 ml/min
  • Hypersensitivity to the active substance or to any of the excipients
  • Dual antiplatelettherapy
  • Dysfunction of thyroid gland
  • Decreased blood coagulation (haemorrhagic diathesis, concomitant therapy with anticoagulants, spontaneous fibrinolysis) and severe thrombocytopenia
  • Aneurysm and arteriovenous malformation
  • Acute pancreatitis, pericarditis, bacterial endocarditis, sepsis
  • Recent trauma including cardiopulmonary resuscitation, thoracic surgery or neurosurgery (e.g. within 2 months)
  • Increased risk of bleeding or previous severe bleeding event
  • known clinical hypersensitivity or prior reactions on contrast agents
  • history of asthma or other allergic troubles
  • Active malignancy
  • life expectancy < 6 month
  • Women, who are pregnant or without sufficient contraception or breastfeeding.
  • Alcohol or drug abuse
  • Employees of the investigator cooperation companies
  • Expected non-compliance
  • Patients unwilling or unable to give informed consent, patients with limited ability to comply with instructions for this study
  • Participation on another clinical trial within the last 3 months
  • Subjects who are committed to an institution and/or penitentiary by judicial or official order
  • Immobility (Depending on wheelchair)

研究者

发起方
Maastricht University Medical Centre

相似试验

A randomised controlled multicenter trial comparing... | 临床试验